March 2010

More recent posts

Byte-sized roundup

30/03/10 permalink This week’s roundup of digital developments includes GSK featuring in the UK web archive, WebMD launches social networking site, Boehringer moots European Twitter expansion, CIM set up social media group and how to quit smoking on FaceBook.

GlaxoSmithKline’s website has been chosen for inclusion in the UK’s first web archive. (Read More.)

The industry’s real social media question

23/03/10 permalink Stop talking platforms and start thinking about what lies behind the dramatic change in communications, says Janssen-Cilag’s Alex Butler in a guest post.

There is a tremendous amount of discussion at the moment about how trust is now the key to corporate reputation. (Read More.)

Novartis' transplant community

19/03/10 permalink Novartis has become the second pharma company to partner with PatientsLikeMe on an online community, working with the site on a section for people who have received organ transplants.

It follows in the footsteps of UCB, which established the first pharma-sponsored patient community on the site last month in epilepsy. (Read More.)

Merck Serono expands PKU website

16/03/10 permalink Merck Serono has expanded its European phenylketonuria disease awareness website, adding versions in French and Spanish.

The website was originally launched in English last November and the company plans to add further European languages, including German and Italian, later this year. (Read More.)

Byte-sized roundup

08/03/10 permalink A roundup of digital developments, including Pfizer’s new Facebook page and beta-phase science blog, Lundbeck, BMS, Baxter and Janssen-Cilag on Twitter, Shire supports Rare Diseases Day, Merck Serono’s fertility survey and NHS online health checks expand to ‘mid-lifers’.

Pfizer has launched an official Facebook page which it hopes will appeal to a wide range of people, including consumers and employees, both past and present. (Read More.)

AZ outlines its online principles

02/03/10 permalink AstraZeneca says it has an obligation to use social media to help empower patients and prescribers to make informed decisions about its products.

The pharma company made the assertion in its submission to the FDA’s ongoing hearing into pharma’s use of social media and the internet. (Read More.)

Older posts